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Primary  retroperitoneal  mucinous  cystadenocarcinoma  is  a  rare  tumor.  Only  about  30  such  cases  have  been 
reported  in  the  worldwide  literature,  and  a  few  Korean  cases  have  been  reported.  The  pathogenesis  is  not  clear,  and 
coelomic  metaplasia  of  the  retroperitoneal  mesothelium  has  gained  wide  support.  There  is  no  consensus  on  the 
appropriate  treatment,  but  surgical  exploration  is  needed  for  the  diagnosis  and  treatment,  and  adjuvant  chemotherapy 
may  be  recommended  following  complete  surgical  excision.  The  long-term  prognosis  has  not  been  established. 
We  report  here  on  a  32-year-old  woman  who  was  diagnosed  as  having  a  retroperitoneal  mucinous 
cystadenocarcinoma  with  mural  nodules  of  sarcomatoid  change.  Tumor  excision  and  adjuvant  chemotherapy  were 
done  and  the  patient  is  doing  well  without  any  evidence  of  recurrence  at  42  months  postoperatively. 
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INTRODUCTION 
Primary  retroperitoneal  mucinous  cystadenocarcinoma  is  a 
rare  tumor  with  only  about  30  reported  cases  in  the  English 
literature.  The  histogenesis  of  this  unusual  neoplasm  is  not 
clear.  Surgical  exploration  is  needed  for  the  diagnosis  and 
treatment,  and  many  authors  recommend  extensive  excision 
including  total  hysterectomy  and  bilateral  salpingo-oophor-
ectomy  with  enucleation  of  retroperitoneal  tumor
1-9).  Adjuvant 
chemotherapy  is  sometimes  administered  following  complete 
surgical  excision
4, 6, 7, 10, 11).  However,  the  most  desirable 
treatment  for  this  rare  tumor  is  still  controversial.  We  report  here 
on  a  patient  who  had  tumor  excision  and  adjuvant 
chemotherapy,  and  the  patient  is  without  evidence  of  recurrence 
42  months  after  surgery.  We  also  review  the  previous  literature 
that's  concerned  with  this  neoplasm. 
CASE REPORT
A  32-year-old  married  woman  was  referred  to  the  surgical 
unit  because  of  a  self-palpable  mass  in  her  left  lower  abdomen   
for  over  1  month  and  the  abdominal  pain  for  the  recent  several 
days.  Physical  examination  revealed  a  slightly  tender,  ill-defined 
mass  about  10  cm  in  size  over  the  left  lower  abdomen.  The 
laboratory  tests,  including  the  complete  blood  count,  the 
chemistry  profile,  urinalysis  and  chest  X-ray,  were  all  within 
normal  limits.  Abdominopelvic  computed  tomography  scanning 
revealed  a  huge  unilocular  cystic  mass  with  an  enhancing  solid 
portion,  and  this  was  probably  located  in  the  retroperitoneal 
space  (Figure  1A,  1B).  There  was  no  evidence  of  extracystic 
extension  or  distant  metastasis. 
Laparotomy  revealed  a  grossly  normal  uterus,  2  ovaries,  2 
fallopian  tubes  and  an  appendix.  There  were  no  abnormal 
findings  in  the  liver,  stomach,  small  bowel,  large  bowel  and The  Korean  Journal  of  Internal  Medicine  :  Vol.  22,  No.  4,  December  2007 288
 
Figure  1.  (A)  Abdominopelvic  computed  tomography  shows  a  large  unilocular  cystic  mass  in  the  left  retroperitoneal  space.  (B)  There  is 
an  enhancing  solid  portion  in  the  posterolateral  aspect  of  the  inner  surface  of  the  cyst.
 
Figure  2.  (A)  The  inner  wall  of  the  cyst  was  lined  by  atypical  columnar  cells  of  mucinous  cystadenocarcinoma  (H&E,  ×100).  (B)  A 
positive  result  for  mucicarmin  staining  in  the  adenocarcinoma  cells  (×200).
spleen.  A  large,  encapsulated  cystic  mass  about  10  cm  in 
diameter  was  found  in  the  retroperitoneum.  It  was  no 
connection  to  the  bowels  and  other  organs.  The  descending 
colon  was  displaced  medially  to  the  mass,  and  no  ascites  was 
found.  Excision  of  the  cystic  mass  was  done.  The  capsule  did 
not  rupture  during  operation.  Hysterectomy,  salpingo- 
oophorectomy,  appendectomy  and  lymphadenectomy  were  not 
performed. 
The  gross  pathologic  findings  showed  a  15×8×7  cm  sized, 
606  gram  cystic  mass.  It  was  unilocular  and  contained  dark 
brown  viscous  material.  The  inner  surface  of  the  cyst  was 
smooth  except  for  three  solid  mural  nodules  that  were  0.8,  1 
and  1.5  cm  in  diameter,  respectively.  The  cystic  wall  measured 
0.7  cm  at  the  maximum  thickness.  There  was  no  evidence  of 
capsular  rupture.  The  mural  nodules  were  soft  and  brownish 
pink.  Microscopically,  the  cyst  was  lined  by  atypical  columnar 
cells  of  mucinous  cystadenocarcinoma  (Figure  2A,  2B).  The 
solid  mural  nodules  showed  highly  pleomorphic  spindle  cells 
and  anaplastic  giant  cells  with  numerous  atypical  mitosis,  and 
there  were  intervening  atypical  glands  of  adenocarcinoma 
(Figure  3A).  The  spindle  and  giant  cells  were  positive  for 
cytokeratin,  vimentin  and  smooth  muscle  actin,  but  negative  for 
S-100  protein  and  desmin  (Figure  3B,  3C).  The  carcinoma  cells 
were  positive  for  cytokeratin  and  they  were  negative  for 
vimentin,  smooth  muscle  actin,  S-100  protein  and  desmin.  The 
diagnosis  of  the  mass  was  primary  retroperitoneal  mucinous 
cystadenocarcinoma  with  mural  nodules  of  sarcomatoid  change. 
The  serum  tumor  markers  were  not  checked  before  tumor 
excision.  At  10  days  after  operation,  the  serum  concentration  of 
CA125  was  elevated  (76.95  IU/mL),  which  decreased  to  within 
normal  limits  3  months  later,  and  the  serum  concentration  of 
CEA  was  normal. 
The  patient  had  an  uneventful  postoperative  recovery. 
Adjuvant  chemotherapy  with  six  courses  of  cyclophosphamide 
AB
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Figure 3. (A)  The  solid  mural  nodules  showed  highly  pleomorphic  spindle  cells and  anaplastic  giant cells  with  numerous atypical mitosis 
(H&E,  ×200).  (B)  The  adenocarcinoma  cells,  spindle  cells  and  giant  cells  were  positive  for  cytokeratin  (×200).  (C)  The  spindle  and  giant 
cells  were  positive  for  vimentin  (×200).
600  mg/m
2  and  cisplatin  60  mg/m
2  was  administered  to  the 
patient.  There  was  no  evidence  of  recurrence  on  the  follow-up 
abdominopelvic  computed  tomography  42  months  after  the 
operation.  Also,  the  CA125  level  was  maintained  at  a  normal 
level. 
DISCUSSION
Primary  retroperitoneal  mucinous  cystadenocarcinoma  is  a 
rare  tumor.  The  first  case  was  described  in  1977  by  Roth  et 
al.
12),  and  about  30  cases  have  been  reported  in  the  English 
medical  literature  to  date. 
Several  hypotheses  have  been  suggested  to  explain  the 
histogenesis  of  primary  retroperitoneal  mucinous  cystic 
neoplasm,  and  they  are  heterotopic  or  supernumerary  ovary
11, 12), 
retroperitoneal  teratoma
13),  intestinal  duplication  and  coelomic 
metaplasia.  To  date,  the  hypothesis  that  has  gained  increasing 
support  is  coelomic  metaplasia,  that  is,  retroperitoneal  mucinous 
cystadenocarcinomas  arise  from  invaginations  of  the  peritoneal 
mesothelium,  with  subsequent  mucinous  metaplasia
1, 3, 4, 5, 12,
14-16).  The  ultrastructural  findings  and  immunohistochemical 
observations  support  this  hypothesis
3,  4). 
The  age  at  diagnosis  ranges  from  17  to  86  years  and  only 
2  of  the  reported  cases  were  male
15).  The  patients  usually  visit 
the  hospital  with  a  complaint  of  abdominal  pain  or  a  palpable 
mass.  Radiologic  tests  including  ultrasonography,  computed 
tomography  or  magnetic  resonance  imaging  are  used  to  localize 
the  tumor  and  evaluate  its  nature.  The  papillary  nodules 
demonstrated  within  a  cyst  by  ultrasonography  or  computed 
tomography  have  been  reported  to  suggest  malignancy
16). 
However,  it  is  often  difficult  to  differentiate  a  benign  from  a 
malignant  neoplasm,  or  even  to  determine  the  origin  site  of  the 
tumor  with  using  the  preoperative  radiologic  images
7).  Serum 
tumor  markers  rarely  assist  in  the  diagnosis  or  follow-up
7). 
Motoyama  et  al.  suggested  that  the  presence  of  glandular 
epithelial  cells  and  high  levels  of  CEA  in  the  cystic  fluid  was 
very  useful  for  making  the  diagnosis
15).  Laparotomy,  tumor 
excision  and  pathologic  examination  are  inevitable  to  make  a 
correct  diagnosis. 
The  treatment  of  primary  retroperitoneal  mucinous  cystaden-
ocarcinoma  remains  controversial.  The  immunohistochemical 
findings  of  this  neoplasm  resemble  those  of  its  ovarian 
counterpart;  thus,  a  large  number  of  authors  recommend 
management  according  to  the  treatment  protocol  for  ovarian 
neoplasms,  including  the  staging  procedure
3, 7).  The  tumor  was 
removed  surgically  in  nearly  all  the  previously  reported  cases. 
Although  almost  all  the  cases,  except  the  one  reported  by 
Uematsu
16)  were  diagnosed  in  the  early  stage,  there  have  been 
many  relapses  cases  in  the  literature
6, 10-14).  Roth  et  al.  reported 
on  a  patient  who  had  undergone  only  tumor  excision  and  he 
died  of  spreading  disease  6  months  postoperatively
12).  Two 
patients  received  tumor  excision  and  adjuvant  chemotherapy, 
but  one  patient  had  a  paraovarian  recurrence  21  months  after 
surgery
10)  and  another  patient  died  of  disease  spread  4  months 
after  surgery
11).  The  patient  with  histologically  borderline 
malignancy  and  who  was  reported  on  by  Banerjee  underwent 
tumor  excision,  left  salpingo-oophorectomy  and  descending 
colon  resection,  and  mediastinal  metastasis  developed  4  years 
later
14).  Mikami  et  al.  noted  a  patient  who  experienced  rupture  of 
the  tumor  capsule  during  the  operation  with  subsequent 
peritoneal  tumor  implantation,  and  the  patient  died  18  months 
after  the  initial  surgery
6).  For  the  Korean  case  reported  on  by 
Song  et  al.,  the  tumor  was  removed  laparoscopically  after  cyst 
aspiration.  Mesenteric  lymphadenopathy  was  found  10  months 
after  surgery  and  the  patient  eventually  expired
13).  Five  of  the 
reported  recurrent  cases  didn't  undergo  extensive  surgical 
excision,  including  hysterectomy  and  bilateral  salpingo-oophor-
ectomy
10-14).  Hysterectomy  and  bilateral  salpingo-oophorectomy 
were  conducted  after  tumor  excision  in  about  half  of  the 
reported  cases
1-9),  and  these  case  were  alive  without  evidence 
of  recurrence  3  to  36  months  postoperatively,  except  for  one 
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case
6).  So,  extensive  exploratory  laparotomy,  including  removal 
of  both  ovaries  and  the  uterus  with  extirpation  of  the 
retroperitoneal  tumor,  may  improve  the  prognosis  and  prevent 
recurrence
1,  2, 5, 11, 17). 
Some  authors  take  an  opposite  view
18, 19).  The  resected 
genital  organs  in  several  reports  showed  no  evidence  of  tumor 
involvement  or  infiltration
1-5, 7-9).  The  only  three  of  all  the  reported 
cases  showed  long-term  survival  (>5  years)  of  6  years,  5  years 
and  5  years,  respectively,  and  these  cases  had  not  undergone 
hysterectomy  and  bilateral  salpingo-oophorectomy
16, 18, 19).  Law  et 
al.  recommended  only  tumor  excision  for  young  women  who 
have  no  evidence  of  disease  dissemination  and  who  hope  to 
stay  fertile
19). 
Six  cases,  including  the  present  case,  have  reported  tumor 
that  had  one  or  more  mural  nodules
6, 8, 9, 11, 12),  and  these 
nodules  satisfied  the  diagnostic  criteria  presented  by  Baergen. 
These  mural  nodules  were  composed  of  poorly  differentiated 
adenocarcinoma,  sarcomatoid  or  sarcoma.  Mikami  et  al. 
reported  a  patient  with  primary  retroperitoneal  mucinous 
cystadenocarcinoma  with  a  mural  nodule,  and  this  nodule  was 
composed  of  pleomorphic  sarcomatoid  cells  with  mitotic 
figures
6).  The  patient  died  of  her  disease  at  18  months 
postoperatively.  The  authors  commented  that  intraoperative 
rupture  of  the  cyst  in  this  case  may  have  resulted  in  its 
peritoneal  dissemination  and  recurrence.  Two  patients  with 
mural  nodules  died  of  disease  at  4  months  and  6  months 
postoperatively,  respectively
11, 12).  One  case  showed  no  evidence 
of  recurrence  18  months  postoperatively
9).  Cases  with  a  mural 
nodule  may  have  an  aggressive  prognosis  like  ovarian  cancers 
with  a  mural  nodule;  therefore,  all  mural  nodules  warrant  careful 
histological  assessment  and  careful  postoperative  follow-up
6, 8). 
Although  our  patient  was  diagnosed  as  having  a  neoplasm  with 
mural  nodules  of  sarcomatoid  change,  she  is  doing  well  without 
evidence  of  recurrence  42  months  postoperatively. 
Cystic  tumor  rupture  during  operation  may  occur,  and 
malignant  cells  may  exist  in  the  spilled  fluid;  this  results  in 
peritoneal  dissemination.  Among  the  patients  with  cystic  rupture
4, 6), 
one  patient  died  18  months  postoperatively
6).  In  contrast, 
another  patient  reported  by  Tenti  et  al.  was  free  of  tumor  33 
months  postoperatively,  and  that  patients  underwent  adjuvant 
chemotherapy
4).  In  the  literatures,  adjuvant  chemotherapy  was 
performed  in  5  patients  after  tumor  resection
4, 6, 7, 10, 11).  One  of 
them  underwent  cytoxan  chemotherapy  for  21  months,  but 
paraovarian  recurrence  developed
10).  2  other  patients  died  4 
months  and  18  months  after  surgery,  respectively,  of 
widespread  metastasis
6, 11).  The  advantage  of  adjuvant 
chemotherapy  has  not  been  proved,  and  tumor  might  be  hard 
to  cure  when  it  recurs,  but  patients  may  have  benefit  from 
chemotherapy  if  the  cyst  ruptures  or  if  extracystic  extension  is 
present
16).
In  the  present  case,  tumor  resection  and  adjuvant 
chemotherapy  were  performed.  Capsular  rupture  did  not  occur, 
but  3  mural  nodules  of  sarcomatoid  change  were  observed.  The 
patient  has  no  evidence  of  recurrence  on  follow-up  computed 
tomography  and  according  to  the  level  of  tumor  marker.  We 
recommend  careful  histologic  examination  of  the  excised 
specimen  and  if  possible,  aggressive  management  with 
extensive  surgical  excision  and  adjuvant  chemotherapy  to 
prevent  recurrence,  and  consideration  must  be  given  to  the 
patient's  age,  the  extent  of  disease  and  the  histologic  findings. 
Primary  retroperitoneal  mucinous  cystadenocarcinoma  is  a  rare 
tumor  and  in  all  reported  cases,  the  duration  of  follow-up  was 
not  more  than  5  years.  Long-term  follow-up  is  essential  to 
evaluate  the  course  and  prognosis  of  this  disease. 
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